Effects of Clinical Pathways for COPD on Patient, Professional, and Systems Outcomes: A Systematic Review.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
11 2019
Historique:
received: 11 10 2018
revised: 18 04 2019
accepted: 29 04 2019
pubmed: 1 6 2019
medline: 23 6 2020
entrez: 1 6 2019
Statut: ppublish

Résumé

COPD has a substantial burden seen in both patient quality of life and health-care costs. One method of minimizing this burden is the implementation of clinical pathways (CPWs). CPWs bring the best available evidence to a range of health-care professionals by adapting guidelines to a local context and detailing essential steps in care. A systematic review was conducted to address the following question: What are the effects of CPWs for COPD on patient-, professional-, and systems-level outcomes? The review used methods outlined by the Cochrane Collaboration. We included all studies that met our operational definition for CPWs and focused on COPD. All studies were evaluated for risk of bias, and all data regarding patient, professional, and systems outcomes were extracted. The search strategy identified 497 potentially relevant titles. Of these, 13 studies were included in the review. These studies reported a total of 398 outcomes, with sufficient data for meta-analysis of five outcomes: complications, length of stay, mortality, readmissions, and quality of life. Results showed statistically significant reductions in complications, readmissions, and length of stay but did not show changes in mortality or quality of life. This systematic review reveals evidence to suggest that CPWs for COPD have the potential to reduce complications, readmissions, and length of stay without negatively influencing mortality or quality of life. However, quality of evidence was generally low. The authors therefore acknowledge that results should be interpreted with caution and note the need for additional research in this area.

Sections du résumé

BACKGROUND
COPD has a substantial burden seen in both patient quality of life and health-care costs. One method of minimizing this burden is the implementation of clinical pathways (CPWs). CPWs bring the best available evidence to a range of health-care professionals by adapting guidelines to a local context and detailing essential steps in care.
METHODS
A systematic review was conducted to address the following question: What are the effects of CPWs for COPD on patient-, professional-, and systems-level outcomes? The review used methods outlined by the Cochrane Collaboration. We included all studies that met our operational definition for CPWs and focused on COPD. All studies were evaluated for risk of bias, and all data regarding patient, professional, and systems outcomes were extracted.
RESULTS
The search strategy identified 497 potentially relevant titles. Of these, 13 studies were included in the review. These studies reported a total of 398 outcomes, with sufficient data for meta-analysis of five outcomes: complications, length of stay, mortality, readmissions, and quality of life. Results showed statistically significant reductions in complications, readmissions, and length of stay but did not show changes in mortality or quality of life.
CONCLUSIONS
This systematic review reveals evidence to suggest that CPWs for COPD have the potential to reduce complications, readmissions, and length of stay without negatively influencing mortality or quality of life. However, quality of evidence was generally low. The authors therefore acknowledge that results should be interpreted with caution and note the need for additional research in this area.

Identifiants

pubmed: 31150639
pii: S0012-3692(19)31120-1
doi: 10.1016/j.chest.2019.04.131
pii:
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

864-877

Investigateurs

Sheila Anderson (S)
Margaret Baker (M)
Zenon Belak (Z)
Nishen Bhagaloo (N)
Terry Blackmore (T)
Bree Calland (B)
Hilda Chan (H)
Patricia Comfort (P)
Tania Diener (T)
Ron Epp (R)
Milo Fink (M)
Carmen Johnson (C)
Barb Konstantynowicz (B)
Jayne Leibel (J)
Winston Lok (W)
Mohammed Moolla (M)
Dodi Novak (D)
Frank Offiah (F)
Prakash Patel (P)
Terry Ross (T)
Ron Taylor (R)
Fouche Williams (F)

Informations de copyright

Copyright © 2019 American College of Chest Physicians. All rights reserved.

Auteurs

Christopher T Plishka (CT)

College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada. Electronic address: chris.plishka@usask.ca.

Thomas Rotter (T)

Health Quality Programs, School of Nursing, Queen's University, Kingston, ON, Canada.

Erika D Penz (ED)

Division of Respirology, Critical Care and Sleep Medicine, Department of Medicine, Respiratory Research Center, University of Saskatchewan, Saskatoon, SK, Canada.

Mohammed R Hansia (MR)

Saskatchewan Health Authority, Saskatoon, SK, Canada.

Shana-Kay A Fraser (SA)

British Virgin Islands Health Services Authority, Road Town, Tortola, British Virgin Islands.

Darcy D Marciniuk (DD)

Division of Respirology, Critical Care and Sleep Medicine, Department of Medicine, Respiratory Research Center, University of Saskatchewan, Saskatoon, SK, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH